Boston Scientific Corporation (NYSE:BSX) Q3 2022 Earnings Conference Call October 26, 2022 8:00 AM ET
Company Participants
Lauren Tengler - Vice President, Investor Relations
Mike Mahoney - Chairman & Chief Executive Officer
Dan Brennan - Executive Vice President & Chief Financial Officer
Ian Meredith - Chief Medical Officer
Ken Stein - Chief Medical Officer
Conference Call Participants
Robbie Marcus - JPMorgan
Larry Biegelsen - Wells Fargo
Joanne Wuensch - Citi
Vijay Kumar - Evercore
Travis Steed - Bank of America
Cecilia Furlong - Morgan Stanley
Rick Wise - Stifel
Matthew O'Brien - Piper Jaffray
Matt Taylor - Jefferies
Pito Chickering - Deutsche Bank
Chris Pasquale - Nephron Research
Matt Miksic - Barclays
Operator
Good morning and welcome to the Boston Scientific Third Quarter 2022 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Lauren Tengler, Vice President, Investor Relations. Please go ahead.
Lauren Tengler
Thank you, Andrew. Welcome, everyone, and thanks for joining us today. With me on today’s call are Mike Mahoney, Chairman and Chief Executive Officer; and Dan Brennan, Executive Vice President and Chief Financial Officer.
We issued a press release earlier this morning announcing our Q3 2022 results, which included reconciliations of the non-GAAP measures used in the release. We have posted a copy of that release as well as reconciliations of the non-GAAP measures used in today’s call to the Investor Relations section of our website under the heading Financials & Filings.
The duration of this morning’s call will be approximately one hour. Mike and Dan will provide comments on Q3 performance as well as the outlook for our business, including Q4 2022 and full year
- Read more current BSX analysis and news
- View all earnings call transcripts